Recent News
On February 12, 2026 the company updated its revenue presentation and highlighted strategic product and partnership activity, noting the integration of secureWISE and expanded licensing for AI and analytics tools, deployment of eProbe into manufacturing, and the launch of Exensio Scalable Analytics. Coverage in mid‑February and late‑February emphasized the company’s positioning as a broader semiconductor execution platform and noted new institutional interest from a small‑cap fund manager.
Technical Analysis
ADX at 20.6 signals an emerging trend in place; strength remains modest, so price follow‑through requires confirmation. This reading frames near‑term price moves as trend‑forming rather than established.
DI+ sits at 27.67 with a peak‑and‑reverse pattern, which reads as a bearish rotation in directional momentum. DI‑ at 19.5 also shows a peak‑and‑reverse pattern but in the opposite sense; that pattern in DI‑ implies a bullish shift. The simultaneous peak‑and‑reverse signatures in both directional indicators point to a transient tug‑of‑war between buyers and sellers rather than a decisive directional breakout.
MACD at 0.57 has dipped and reversed and currently stands above its signal line at 0.39; that cross above the signal line represents a bullish momentum pickup and supports the short‑term upside case tied to the introduction of new platform offerings.
MRO reads 24.17 and has trended higher; the positive MRO indicates price lies above the model target and therefore carries potential downward pressure if momentum fails to sustain. The increasing MRO suggests the magnitude of that divergence has grown and merits attention as a reversion risk.
RSI at 55.67 reversed up from a dip, indicating constructive near‑term momentum without reaching overbought territory. That pattern aligns with the MACD bullish turn and supports a measured continuation of the recent advance.
Price sits at $34.00 above the 20‑day average ($33.00), 50‑day average ($31.72) and 200‑day average ($25.47). Short‑term EMAs (12‑day $33.14 and 26‑day $32.53) show a dip‑and‑reversal, which reinforces the momentum signal while Bollinger band levels ($34.21 upper 1σ, $31.79 lower 1σ) place current price near the upper band but within the 2σ envelope—consistent with controlled upside rather than extreme extension.
Fundamental Analysis
Earnings: Reported EPS of $0.30 versus an estimate of $0.24 produced an EPS surprise of +25.0%. Forward EPS sits at $0.3425 and forward PE equals 79.62, which implies lower forward multiple compression relative to the current PE of 100.21.
Earnings growth shows meaningful deterioration: earnings growth YoY at -53.125% and earnings growth QoQ at -122.431%. Those declines contrast with the EPS beat, indicating the beat reflects margin or non‑recurring adjustments rather than a recovering top line.
Revenue metrics in the provided data show revenue growth at 0.0% with QoQ revenue growth at -100.0% and YoY revenue growth at -100.0% (values supplied). Such readings portray material near‑term top‑line weakness in the dataset and warrant reconciliation with company statements on platform expansion when assessing sustainability.
Valuation context: Trailing PE at $100.21 lies below the industry peer mean of 139.60 and below the industry peer median of 144.22; forward PE at $79.62 also sits below the industry peer mean of 90.03 and median of 90.60. PEG (current) at -1.89 compares below the industry peer mean of 0.90 and median of 2.76, reflecting negative or atypical growth adjustments. WMDST values the stock as fair‑valued given this mix of earnings weakness, forward multiple compression, and product/scale catalysts.
Capital structure and cash: cost of debt at 1.323% remains low. Invested capital total reported at $37,904,000 supports ongoing platform investment but cash conversion and cash‑flow metrics require closer monitoring given the reported earnings growth decline and the revenue growth readings above.
MOST-RECENT QUARTERLY REPORT
| REPORT PERIOD ENDING: | 2025-12-31 |
| REPORT DATE: | 2026-02-12 |
| NEXT REPORT DATE: | 2026-05-14 |
| CASH FLOW | Begin Period Cash Flow | — |
| Operating Cash Flow | — | |
| Capital Expenditures | — | |
| Change In Working Capital | — | |
| Dividends Paid | — | |
| Cash Flow Delta | — | |
| End Period Cash Flow | — | |
| INCOME STATEMENT | REVENUE | |
| Total Revenue | — | |
| Forward Revenue | — | |
| COSTS | ||
| Cost Of Revenue | — | |
| Depreciation | — | |
| Depreciation and Amortization | — | |
| Research and Development | — | |
| Total Operating Expenses | — | |
| PROFITABILITY | ||
| Gross Profit | — | |
| EBITDA | — | |
| EBIT | — | |
| Operating Income | — | |
| Interest Income | — | |
| Interest Expense | — | |
| Net Interest Income | — | |
| Income Before Tax | — | |
| Tax Provision | — | |
| Tax Rate | — | |
| Net Income | — | |
| Net Income From Continuing Operations | — | |
| EARNINGS | ||
| EPS Estimate | $ 0.24 | |
| EPS Actual | $ 0.30 | |
| EPS Difference | $ 0.06 | |
| EPS Surprise | 25.0 % | |
| Forward EPS | $ 0.34 | |
| BALANCE SHEET | ASSETS | |
| Total Assets | — | |
| Intangible Assets | — | |
| Net Tangible Assets | — | |
| Total Current Assets | — | |
| Cash and Short-Term Investments | — | |
| Cash | — | |
| Net Receivables | — | |
| Inventory | — | |
| Long-Term Investments | — | |
| LIABILITIES | ||
| Accounts Payable | — | |
| Short-Term Debt | — | |
| Total Current Liabilities | — | |
| Net Debt | — | |
| Total Debt | — | |
| Total Liabilities | — | |
| EQUITY | ||
| Total Equity | — | |
| Retained Earnings | — | |
| VALUATION & PER-SHARE METRICS | EQUITY & PER-SHARE METRICS | |
| Book Value Per-Share | — | |
| Shares Outstanding | — | |
| Revenue Per-Share | — | |
| VALUATION | Market Capitalization | — |
| Enterprise Value | — | |
| Enterprise Multiple | — | |
| Enterprise Multiple QoQ | — | |
| Enterprise Multiple YoY | — | |
| Enterprise Multiple IPRWA | — | |
| EV/R | — | |
| CAPITAL STRUCTURE | ||
| Asset To Equity | — | |
| Asset To Liability | — | |
| Debt To Capital | — | |
| Debt To Assets | — | |
| Debt To Assets QoQ | — | |
| Debt To Assets YoY | — | |
| Debt To Assets IPRWA | — | |
| Debt To Equity | — | |
| Debt To Equity QoQ | — | |
| Debt To Equity YoY | — | |
| Debt To Equity IPRWA | — | |
| PRICE-BASED VALUATION | ||
| Price To Book (P/B) | — | |
| Price To Book QoQ | — | |
| Price To Book YoY | — | |
| Price To Book IPRWA | — | |
| Price To Earnings (P/E) | 100.21 | |
| Price To Earnings QoQ | 156.144 % | |
| Price To Earnings YoY | -12.527 % | |
| Price To Earnings IPRWA | high: 422.129 median: 144.216 mean: 139.599 PDFS: 100.21 low: -305.594 |
|
| PE/G Ratio | -1.886 | |
| Price To Sales (P/S) | — | |
| Price To Sales QoQ | — | |
| Price To Sales YoY | — | |
| Price To Sales IPRWA | — | |
| FORWARD MULTIPLES | ||
| Forward P/E | 79.625 | |
| Forward PE/G | -1.499 | |
| Forward P/S | — | |
| EFFICIENCY | OPERATIONAL | |
| Operating Leverage | — | |
| ASSET & SALES | ||
| Asset Turnover Ratio | — | |
| Asset Turnover Ratio QoQ | — | |
| Asset Turnover Ratio YoY | — | |
| Asset Turnover Ratio IPRWA | — | |
| Receivables Turnover | — | |
| Receivables Turnover Ratio QoQ | — | |
| Receivables Turnover Ratio YoY | — | |
| Receivables Turnover Ratio IPRWA | — | |
| Inventory Turnover | — | |
| Inventory Turnover Ratio QoQ | — | |
| Inventory Turnover Ratio YoY | — | |
| Inventory Turnover Ratio IPRWA | — | |
| Days Sales Outstanding (DSO) | — | |
| CASH CYCLE | ||
| Cash Conversion Cycle Days (CCC) | — | |
| Cash Conversion Cycle Days QoQ | — | |
| Cash Conversion Cycle Days YoY | — | |
| Cash Conversion Cycle Days IPRWA | high: 596.302 median: 270.338 mean: 255.66 low: 62.399 PDFS: 0 |
|
| CAPITAL DEPLOYMENT | ||
| Cash Conversion Ratio | — | |
| CapEx To Revenue | — | |
| CapEx To Depreciation | — | |
| CAPITAL, LIQUIDITY & COVERAGE | CAPITAL STRUCTURE | |
| Total Capital | — | |
| Net Invested Capital | — | |
| Invested Capital | $ 37.9 M | |
| Net Tangible Assets | — | |
| Net Working Capital | — | |
| LIQUIDITY | ||
| Cash Ratio | — | |
| Current Ratio | — | |
| Current Ratio QoQ | — | |
| Current Ratio YoY | — | |
| Current Ratio IPRWA | — | |
| Quick Ratio | — | |
| Quick Ratio QoQ | — | |
| Quick Ratio YoY | — | |
| Quick Ratio IPRWA | — | |
| COVERAGE & LEVERAGE | ||
| Debt To EBITDA | — | |
| Cost Of Debt | 1.323 % | |
| Interest Coverage Ratio | — | |
| Interest Coverage Ratio QoQ | — | |
| Interest Coverage Ratio YoY | — | |
| Interest Coverage Ratio IPRWA | — | |
| Operating Cash Flow Ratio | — | |
| TIMING / LIQUIDITY | ||
| Days Payables Outstanding (DPO) | — | |
| DIVIDENDS | ||
| Dividend Coverage Ratio | — | |
| Dividend Payout Ratio | — | |
| Dividend Rate | — | |
| Dividend Yield | — | |
| PERFORMANCE | GROWTH | |
| Asset Growth Rate | — | |
| Revenue Growth | 0.0 % | |
| Revenue Growth QoQ | -100.0 % | |
| Revenue Growth YoY | -100.0 % | |
| Revenue Growth IPRWA | high: 40.838 % mean: 12.876 % median: 2.725 % PDFS: 0.0 % low: -9.892 % |
|
| Earnings Growth | -53.125 % | |
| Earnings Growth QoQ | -122.431 % | |
| Earnings Growth YoY | — | |
| Earnings Growth IPRWA | high: 266.667 % mean: 17.687 % median: 0.454 % PDFS: -53.125 % low: -85.714 % |
|
| MARGINS | ||
| Gross Margin | — | |
| Gross Margin QoQ | — | |
| Gross Margin YoY | — | |
| Gross Margin IPRWA | — | |
| EBIT Margin | — | |
| EBIT Margin QoQ | — | |
| EBIT Margin YoY | — | |
| EBIT Margin IPRWA | — | |
| Return On Sales (ROS) | — | |
| Return On Sales QoQ | — | |
| Return On Sales YoY | — | |
| Return On Sales IPRWA | — | |
| CASH FLOW | ||
| Free Cash Flow (FCF) | — | |
| Free Cash Flow Yield | — | |
| Free Cash Flow Yield QoQ | — | |
| Free Cash Flow Yield YoY | — | |
| Free Cash Flow Yield IPRWA | — | |
| Free Cash Growth | — | |
| Free Cash Growth QoQ | — | |
| Free Cash Growth YoY | — | |
| Free Cash Growth IPRWA | — | |
| Free Cash To Net Income | — | |
| Cash Flow Margin | 0.0 % | |
| Cash Flow To Earnings | 0.0 | |
| VALUE & RETURNS | ||
| Economic Value Added | — | |
| Return On Assets (ROA) | — | |
| Return On Assets QoQ | — | |
| Return On Assets YoY | — | |
| Return On Assets IPRWA | — | |
| Return On Capital Employed (ROCE) | — | |
| Return On Equity (ROE) | — | |
| Return On Equity QoQ | — | |
| Return On Equity YoY | — | |
| Return On Equity IPRWA | — | |
| DuPont ROE | — | |
| Return On Invested Capital (ROIC) | — | |
| Return On Invested Capital QoQ | — | |
| Return On Invested Capital YoY | — | |
| Return On Invested Capital IPRWA | — | |